Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Stress-management program to reduce heart disease risk in women with HIV

Official title: Adapting and Piloting a Stress Management Intervention to Reduce Cardiovascular Disease Risk Among Women Living With HIV

Run by University of Alabama at Birmingham · NCT06811896 · Data updated 2026-11-12

This program will test whether the SMART stress-management intervention can lower blood pressure and other heart-disease risks for women living with HIV in the Southern US.

More Blood Pressure trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment48 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations1 site (Birmingham, Alabama)
StatusRecruiting
StartedMay 14, 2025
Main results expectedApril 2027
Study endsApril 2028
Registry record updatedSeptember 28, 2026
Trial IDNCT06811896 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking cisgender women aged 18 or older who are HIV-positive, receive care at the recruiting clinic, and are willing and able to attend study visits and provide consent.

Probably not a fit

People with severe mental illness, those unwilling or unable to provide informed consent or attend study visits, non-English speakers, and men would not be expected to benefit from this specific program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project adapts the Stress Management and Resiliency Training (SMART) program for cisgender women living with HIV who receive care at a clinic in the Southern US and compares that intervention to usual care. Participants who meet eligibility will be enrolled at the University of Alabama at Birmingham and assigned to receive the SMART intervention or continue with usual care while researchers collect health and stress-related measures. The intervention focuses on resiliency skills, meditation, and techniques to reduce physiological stress responses known to contribute to cardiovascular disease. Outcomes include blood pressure and other markers of cardiovascular risk and stress over the follow-up period.

Why it matters

Potential benefit: If successful, the program could lower blood pressure and reduce long-term cardiovascular risk by improving stress resilience.

How similar studies have gone: The SMART program has demonstrated efficacy in diverse populations for reducing stress responses, but it has not previously been adapted or tested specifically among women living with HIV in the Southern US.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. cis-gender females at least 18 years of age
2. HIV-seropositive and a patient of the recruiting clinic
3. English speaking

Exclusion Criteria:

1. severe mental illness
2. not being willing able to provide informed consent
3. not willing or able to attend study visits

Where it's running

  • University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.